Getein Biotech (SHSE:603387) Beginning Cash Position : ¥483 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Getein Biotech Beginning Cash Position?

Getein Biotech's Beginning Cash Position for the quarter that ended in Mar. 2024 was ¥483 Mil.

Getein Biotech's quarterly Beginning Cash Position declined from Sep. 2023 (¥537 Mil) to Dec. 2023 (¥408 Mil) but then increased from Dec. 2023 (¥408 Mil) to Mar. 2024 (¥483 Mil).

Getein Biotech's annual Beginning Cash Position increased from Dec. 2021 (¥797 Mil) to Dec. 2022 (¥945 Mil) but then declined from Dec. 2022 (¥945 Mil) to Dec. 2023 (¥641 Mil).

Getein Biotech Beginning Cash Position Historical Data

The historical data trend for Getein Biotech's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Getein Biotech Beginning Cash Position Chart

Getein Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

142.41

656.65

797.37

945.15

640.99

Getein Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															644.64	729.32	537.20	408.34	483.18

Getein Biotech Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Getein Biotech Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Getein Biotech's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Getein Biotech (SHSE:603387) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Getein Biotech Inc (SHSE:603387) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 9 Bofu Road, Luhe District, Nanjing, CHN, 211505

Website

http://www.bio-gp.com.cn

Getein Biotech Inc is an in-vitro diagnostic company. It is specializing in analytical medical devices and point-of-care testing kits. Its product lines consist of cardiovascular, inflammatory, diabetes, fertility, renal, liver and specialty assays.

Executives

Su En Kui	Director
Yan Bin	Director
Kong Ting Ting	Director
Xu Xing De	Director
Su En Ben	Director

Getein Biotech (SHSE:603387) Headlines

No Headlines